Steripath® Micro | Magnolia Medical Technologies

Protect your most precious patients

from the risks associated with false-positive blood culture results with the newest Initial Specimen Diversion Device^®

Request Demo

Clinically Proven Technology

Designed with trusted ISDD^® technology and feedback from leading U.S. hospitals⁺

FDA-Cleared

FDA 510(k)-cleared and indicated to reduce blood culture contamination¹

Guaranteed Results

Guaranteed to reduce blood culture contamination by at least 50%, or your money back²

Meet Steripath Micro

the newest & most intuitive Initial Specimen Diversion Device® designed to defend your most vulnerable patients from associated risks of contaminated blood culture results.

Practicality Meets Precision

Designed for effortless contaminant diversion & blood culture collection

Low Diversion Volume

Diverts only 0.6-0.9mL of blood, designed for patients with low-blood volume and difficult venous access.

Easy to Use

Simply pull a plunger and press a button. Lightweight, intuitive design for seamless compliance.

Syringe-Driven Diversion

Micro doesn’t rely on your patient’s venous pressure, making difficult draws easier and faster.

Collect blood cultures, with confidence.

The Steripath® Micro Blood Culture Collection System includes a 7” CT-compatible Luer extension set and of 5mL, 10mL & 20mL syringe configurations.

References: +) * Multiple studies (Rupp M., et al; “Reduction in Blood Culture Contamination Through Use of Initial Specimen Diversion Device.” Clinical Infectious Diseases (Aug. 2017); Bell, M., et al. (2018). Effectiveness of a Novel Specimen Collection System in Reducing Blood Culture Contamination Rates. Journal of Emergency Nursing, 44(6): 570-5753; (1) indicated for use as a blood collection system that diverts and sequesters the initial specimen prior to collection of a subsequent test sample to reduce the frequency of blood culture contamination when contaminants are present in the initial blood sample compared to blood cultures drawn with standard procedure without manual diversion. (2) Additional terms and conditions apply (3) Doern, G., et al. “A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem.” Clinical Microbiology Reviews (Jan. 2019)